financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Analog Devices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Analog Devices
Nov 25, 2025 9:58 AM

12:40 PM EST, 11/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price to $280 from $265, based on a P/E of 25x our CY 2027 EPS forecast of $11.20, within historical and peer averages. Based on better-than-expected Oct-Q results, we raise our FY 26 (Oct.) EPS estimate to $9.58 from $9.06 and FY 27's to $11.10 from $10.80. ADI's diverse design pipeline grew over 20% in FY 25, with particular strength in its AI-driven ATE business, automation/robotics, energy infrastructure, and data center connectivity solutions. Looking ahead, we believe the company is well positioned to continue growing in FY 26, as the cyclical recovery is sustained and secular opportunities drive higher content growth. We see demand supported by expanding opportunities in AI infrastructure and automotive ADAS systems while long-term prospects are emerging from applications like humanoid robotics. Inventories across the channel remain relatively lean, at around six to seven weeks, as customers remain prudent amid ongoing macroeconomic and geopolitical uncertainties.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Hold Opinion On Shares Of Moderna, Inc.
Research Alert: CFRA Retains Hold Opinion On Shares Of Moderna, Inc.
May 31, 2024
01:15 PM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: In line with expectations, Moderna ( MRNA ) secured the FDA approval for its mRNA-based RSV vaccine, mRESVIA(R), today for adults 60 years and older. Following the approval of its...
Research Alert: CFRA Keeps Hold Opinion On Shares Of The Cooper Companies
Research Alert: CFRA Keeps Hold Opinion On Shares Of The Cooper Companies
May 31, 2024
01:10 PM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $103, on a forward P/E of 26x our FY 2025 (Oct.) earnings estimate, a modest discount to the company's five-year historic average at...
Research Alert: CFRA Lowers Opinion On Shares Of Paycom Software, Inc. To Buy From Strong Buy
Research Alert: CFRA Lowers Opinion On Shares Of Paycom Software, Inc. To Buy From Strong Buy
May 31, 2024
03:05 PM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Shares of PAYC are selling off today after the company announced a few executive changes, the most notable one being that Christopher Thomas resigned from his position as Co-CEO of...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Heico Corporation
Research Alert: CFRA Keeps Sell Opinion On Shares Of Heico Corporation
May 31, 2024
11:30 AM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $190, up $14, reflects a 45x multiple of projected FY 2025 (Oct.) EPS, above HEI's historical forward average. We lift our FY 2024 EPS estimate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved